NEWS

FDA volte-face on study powers jolts Acadia; watt’s next in DRP?

Acadia Pharmaceuticals Inc. President Serge Stankovic said the company was “kept completely in [the] dark” by the FDA regarding specifics about what the agency found wrong a month ago with the sNDA …
( read original story …)


Related Posts